Search research articles
Contact Us
Filters
Showing results (561-570 of 575) with videos related to
Page
of 58
Sort By:
Frontiers in Neurology
|
June 20, 2022
Impact of Body Temperature in Patients With Acute Basilar Artery Occlusion: Analysis of the BASILAR Database
Wenbin Zhang, Fengli Li, Cai Zhang, et al.
Nature Cell Biology
|
March 3, 2025
ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion
Yuran Duan, Zhiqiang Hu, Peng Han, et al.
Nucleic Acids Research
|
October 5, 2017
qPrimerDB: a thermodynamics-based gene-specific qPCR primer database for 147 organisms
Kun Lu, Tian Li, Jian He, et al.
Neuroepidemiology
|
August 12, 2024
Rates and Impact of Serious Adverse Events after Endovascular Thrombectomy among Large Vessel Occlusion Stroke Patients
Bo Lei, Shuang Yang, Ling Tian, et al.
Nature Genetics
|
August 11, 2014
Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3
Shengping Hou, Liping Du, Bo Lei, et al.
Journal of Medical Case Reports
|
December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
The Lancet Regional Health. Western Pacific
|
June 20, 2025
Early intensive blood pressure management after endovascular treatment in ischaemic stroke (IDENTIFY): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Xuening Zhang, Le Cao, Simiao Wu, et al.
Stroke
|
May 11, 2023
Effect of Imaging Selection Paradigms on Endovascular Thrombectomy Outcomes in Patients With Acute Ischemic Stroke
Jian Miao, Hongfei Sang, Fengli Li, et al.
Journal of Hematology & Oncology
|
December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology
|
July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 575) with videos related to
Sort By:
Page
of 58
Frontiers in Neurology
|
June 20, 2022
Impact of Body Temperature in Patients With Acute Basilar Artery Occlusion: Analysis of the BASILAR Database
Wenbin Zhang, Fengli Li, Cai Zhang, et al.
Nature Cell Biology
|
March 3, 2025
ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion
Yuran Duan, Zhiqiang Hu, Peng Han, et al.
Nucleic Acids Research
|
October 5, 2017
qPrimerDB: a thermodynamics-based gene-specific qPCR primer database for 147 organisms
Kun Lu, Tian Li, Jian He, et al.
Neuroepidemiology
|
August 12, 2024
Rates and Impact of Serious Adverse Events after Endovascular Thrombectomy among Large Vessel Occlusion Stroke Patients
Bo Lei, Shuang Yang, Ling Tian, et al.
Nature Genetics
|
August 11, 2014
Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3
Shengping Hou, Liping Du, Bo Lei, et al.
Journal of Medical Case Reports
|
December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
The Lancet Regional Health. Western Pacific
|
June 20, 2025
Early intensive blood pressure management after endovascular treatment in ischaemic stroke (IDENTIFY): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Xuening Zhang, Le Cao, Simiao Wu, et al.
Stroke
|
May 11, 2023
Effect of Imaging Selection Paradigms on Endovascular Thrombectomy Outcomes in Patients With Acute Ischemic Stroke
Jian Miao, Hongfei Sang, Fengli Li, et al.
Journal of Hematology & Oncology
|
December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology
|
July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Page
of 58